Telehealth Music Therapy for adults with autoimmune endocrine disease and depression

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention development study will enroll 8-10 adults with autoimmune endocrine disease and depression to participate in an 8-week telehealth music therapy program led by a board-certified music therapist. Participants will complete baseline and post-intervention assessments on quality of life, depression, anxiety, and their relationship to music, plus a brief interview at the start and end. All participants receive the music therapy in addition to their usual medical care, with outcome measures collected after the 8-week period to inform a future larger trial. The study also aims to refine procedures and establish feasibility for a full-scale efficacy trial in this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* self-reported depression
* self-reported autoimmune endocrine disease
* 18-65 years of age
* have a device that supports the Zoom platform (camera and audio)

Exclusion Criteria:

* intellectual or developmental disability
* no auto-immune disease
* no depression
* lack of access to device
* under the age of 18 years
* over the age of 65 years

Where it's running

• Appalachian State University
  Boone, North Carolina, United States Recruiting

Study contacts

• Principal investigator: Melody Schwantes, PhD, MT-BC — Appalachian State University
• Study coordinator: Melody Schwantes, PhD, MT-BC
• Email: ms18994@appstate.edu
• Phone: 828-262-8216

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• ETHY-001 safety and activity in Thyroid Eye Disease (TED)

  This study tests ETHY-001 versus placebo to see if it is safe, tolerable, and shows activity in people with thyroid eye disease.

  Recruiting at 2 sites Phase 1 Ethyreal Bio, Inc. · Orland Park, Illinois and 2 other locations · NCT07885605

• Efgartigimod for Graves' Disease in adults

  We are testing if efgartigimod given under the skin can help adults with Graves' disease by improving thyroid function and whether it is safe and tolerable.

  Recruiting at 35 sites Phase 3 argenx · Carlsbad, California and 34 other locations · NCT07570316

• Insulin delivery technology and eating behaviours in people with type 1 diabetes

  This project will test whether automated insulin delivery systems change eating behaviours and make carbohydrate counting easier for people aged 12 and older who have type 1 diabetes in Canada.

  Recruiting McGill University · Montreal, Quebec · NCT07348432

• Using the 'Support' online training and peer program for adults with type 1 diabetes

  This project will test whether adults with type 1 diabetes who get access to the online 'Support' training and peer platform through their diabetes clinic manage their diabetes better than those who use the platform on their own.

  Recruiting at 4 sites McGill University · Montreal, Quebec and 3 other locations · NCT06069583

• Using corticosteroids before surgery for autoimmune thyroid disease

  This study tests if taking a short course of corticosteroids before thyroid surgery can help people with Graves' disease or Hashimoto's disease have a smoother operation.

  Recruiting at 3 sites Phase 4 Indiana University · Indianapolis, Indiana and 2 other locations · NCT05435547

• Smartphone-supported single-session psychotherapy for postpartum depression

  A single online therapy session plus four weeks of app-based support is being tested to see if it reduces depressive symptoms in postpartum women compared with a waitlist.

  Recruiting University of Sao Paulo · São Paulo, São Paulo · NCT07925762

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.